Abstract
There is limited experience on engraftment syndrome (ES) in children. The present study analyzes the characteristics of ES in pediatric patients undergoing autologous peripheral blood progenitor cells transplantation (PBPCT). From 1993 to 2001, 30 of 156 patients (19.2%) who underwent PBPCT developed ES (skin rash which involved more than 27% of the body surface and temperature >38.3°C with no compatible infectious disease etiology, during neutrophil recovery). Of the 30 patients who developed ES, 20 (66%) developed hypoxia and/or pulmonary infiltrates, seven (23%) had hepatic dysfunction, six (20%) developed renal insufficiency, 16 (53%) showed weight gain and three (10%) experienced transient encephalopathy. Multivariate analysis showed that the only positive predictive factor for developing ES was mobilization with high-dose G-CSF (12 μg/kg twice daily) (RR 3.88, CI 95% 1.73–8.67; P < 0.0005). The overall transplant-related mortality (TRM) was 8.33% and this was significantly higher in the patients who developed ES than in those who did not (23% vs 4.76%; P < 0.0001). We also found a higher morbidity in patients who developed ES, expressed as a statistically significant increase in supportive care (transfusion requirement, parenteral nutrition) and increase in the length of hospital stay. In summary, we have found ES to be the most important cause of morbidity and mortality in children undergoing autologous PBPCT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ladenstein R, Philip T, Garner H . Autologous stem cell transplantation for solid tumors in children Curr Opin Ped 1997 9: 55 69
Ladenstein R, Lasset C, Pinkerton R et al. Impact of megatherapy in children with high-risk Ewing's tumors in complete remission: a report from EBMT Solid Tumor registry Bone Marrow Transplant 1995 15: 692 705
Díaz MA, Vicent MG, Madero L . High dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors Bone Marrow Transplant 1999 24: 1157 1159
Edenfield WJ, Moores LK, Goodwin G, Lee N . An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose Bone Marrow Transplant 2000 25: 405 409
Moreb JS, Kubilis PS, Mullins DL et al. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients Bone Marrow Transplant 1997 19: 101 106
Ravoet C, Feremans W, Husson B et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation Bone Marrow Transplant 1996 18: 943 947
Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation Bone Marrow Transplant 2001 27: 893 898
Rabinowitz J, Petros WP, Stuart AR et al. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support Blood 1993 81: 2452 2459
Antin J, Ferrara L . Cytokine dysregulation and acute graft-versus host disease Blood 1992 80: 2964 2968
Takatsuka H, Takemoto Y, Yamade S et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome Bone Marrow Transplant 2000 26: 419 426
Díaz MA, Alegre A, Villa M et al. Collection and transplantation of peripheral blood progenitor cells mobilized by G-CSF alone in children with malignancy Br J Haematol 1996 94: 148 154
Madero L, Gonzalez Vicent M, Molina J et al. Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease Bone Marrow Transplant 2000 26: 365 369
Halle P, Kanold J, Rapatel C et al. Granulocyte colony-stimulating factor alone at 20 μg/kg vs 10 μg/kg for peripheral blood stem cell mobilization in children Ped Transplant 2000 4: 285 288
Díaz MA, Alegre A, Benito A et al. Peripheral blood progenitor cell collection by large volume leukapheresis in low-weight children J Hematother 2000 7: 63 68
Alegre A, Díaz MA, Madero L et al. Large-volume leukapheresis for peripheral blood stem cell collection in children: a simplified single apheresis approach Bone Marrow Transplant 1996 17: 923 927
Lee CK, Gringrich RD, Hohl RJ . Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation Bone Marrow Transplant 1995 16: 175 182
Pession A, Rondelli R, Paolucci P et al. Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Haematologica 2000 85: 638 646
Capizzi SA, Kumar S, Huneke NE et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation Bone Marrow Transplant 2001 27: 1299 1303
Horn TD, Redd JV, Karp JE et al. Cutaneous eruption lymphocyte recovery Arch Dermatol 1989 125: 1512 1516
Bauer DJ, Hood AF, Horn TD . Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery Arch Dermatol 1993 129: 855 859
Tanaka R, Matsudaira T, Aizawa J et al. Characterization of peripheral blood progenitor cells (PBPC) mobilized by filgastrim (rHuG-CSF) in normal volunteers: dose–effect relationship for filgastrim with the character of mobilized PBPC Br J Haematol 1996 92: 795 803
Nuremberg W, Willers R, Burdech S et al. Risk factors for capillary leak syndrome after bone marrow transplantation Ann Hematol 1997 74: 221 224
Raptis A, Mavrondis D, Suffreolini A et al. High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients Bone Marrow Transplant 1999 24: 879 883
Metcalf J, Rennard SI, Reed EC et al. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation Am J Med 1994 96: 327 334
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Madero, L., Vicent, M., Sevilla, J. et al. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 30, 355–358 (2002). https://doi.org/10.1038/sj.bmt.1703645
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703645
Keywords
This article is cited by
-
Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management
Medical Oncology (2022)
-
Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
American Journal of Clinical Dermatology (2019)
-
Engraftment syndrome: double-edged sword of hematopoietic cell transplants
Bone Marrow Transplantation (2015)
-
Improving stem cell mobilization strategies: future directions
Bone Marrow Transplantation (2009)
-
Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias
Bone Marrow Transplantation (2006)